These success, together with a prior report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the concept of focusing on ACKR3 as a novel solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Diseases. Publishing this overview means https://stephenz155fvl1.corpfinwiki.com/user